CARRIE MALLEN: Open Payments
NPI 1558520577 · HACKENSACK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$652 in 43 payments from 11 companies in 2025. Trend: 2023 $351 · 2024 $591 · 2025 $652
Food & beverage: $652
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 10 | $177 |
| Incyte Corporation | 12 | $160 |
| GENZYME CORPORATION | 4 | $78 |
| Regeneron Healthcare Solutions, Inc. | 3 | $51 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $50 |
| Amgen Inc. | 2 | $35 |
| Organon LLC | 5 | $33 |
| Lilly USA, LLC | 1 | $19 |
| Janssen Biotech, Inc. | 1 | $19 |
| LNHC, Inc | 1 | $15 |
Products named: OPZELURA, ADBRY, DUPIXENT, Winlevi, ANZUPGO, Otezla, EBGLYSS, TREMFYA.
Industry payments across NJ — which companies pay providers there.
